Anaheim, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Cancer Research Collaboration Inc, founded in 2012, is a small nonprofit in the Medical Research sector that reported $183K in total revenue in fiscal year 2024. Revenue surged 21% from the prior year, signaling strong growth momentum. The organization ran a surplus of $177K, a strong 97% operating margin.
To conduct and fund scientific research for cancer and various medical research projects and clinical studies.
These revenues and expenses are associated with clinical trials funded by pharmaceutical companies, universities, device companies, and diagnostic testing laboratories. The information obtained by...
These revenues and expenses are associated with clinical trials funded by pharmaceutical companies, universities, device companies, and diagnostic testing laboratories. The information obtained by the organization from these clinical studies allows the organization to meet its charitable purposes of offering cutting edge diagnostic testing (to detect cancer as early as possible), creating new drug treatment therapies, and creating molecular interventional strategies to prevent future relapses of cancer. The organization utilizes this information to advise and educate patients who are fighting cancer and other diseases.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $183,281 | $151,199 | +0.2% |
| Expenses | $5,978 | $302,509 | -1.0% |
| Net Income | $177,303 | $-151,310 | -2.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Kristi Maya | President | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| Andre De Fuesco | Board Member | 0.10 |
Officer
|
$0 | $0 | $0 |
| Terrie Herrick | Treasurer | 0.10 |
Officer
|
$0 | $0 | $0 |
| Deborah Saly | Secretary | 0.10 |
Officer
|
$0 | $0 | $0 |
| Terence Webb | Board Member | 0.10 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $183,281 | $5,978 | $1,195,471 | $177,303 |
| 2023 | $151,199 | $302,509 | $1,116,558 | $-151,310 |
| 2022 | $213,380 | $238,786 | $1,171,633 | $-25,406 |
| 2021 | $11,003 | $109,403 | $1,097,037 | $-98,400 |
| 2020 | $66,695 | $36,586 | $1,551,579 | $30,109 |
| 2020 | $68,228 | $179,690 | $1,410,008 | $-111,462 |
| 2019 | $1,740,972 | $1,741,166 | $1,545,255 | $-194 |
| 2018 | $2,055,057 | $1,994,676 | $2,777,018 | $60,381 |
Compare Cancer Research Collaboration Inc with other nonprofits in California and across the country.